Development of optical biosensor technologies for cardiac troponin recognition.

Anal Biochem

Department of Developmental Sciences, Marquette University School of Dentistry, Milwaukee, WI 53201, USA; Biomaterials and Advanced Drug Delivery Laboratory, School of Medicine, Stanford University, Palo Alto, CA 94304, USA.

Published: September 2015

Acute myocardial infarction (AMI) is the leading cause of death among cardiovascular diseases. Among the numerous attempts to develop coronary marker concepts into clinical strategies, cardiac troponin is known as a specific marker for coronary events. The cardiac troponin concentration level in blood has been shown to rise rapidly for 4-10 days after onset of AMI, making it an attractive approach for a long diagnosis window for detection. The extremely low clinical sensing range of cardiac troponin levels consequently makes the methods of detection highly sensitive. In this review, by taking into consideration optical methods applied for cardiac troponin detection, we discuss the most commonly used methods of optical immunosensing and provide an overview of the various diagnostic cardiac troponin immunosensors that have been employed for determination of cardiac troponin over the last several years.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ab.2015.06.003DOI Listing

Publication Analysis

Top Keywords

cardiac troponin
28
cardiac
7
troponin
7
development optical
4
optical biosensor
4
biosensor technologies
4
technologies cardiac
4
troponin recognition
4
recognition acute
4
acute myocardial
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!